Xenon Pharmaceuticals (XENE) Preferred Dividend Payments (2013 - 2022)

Xenon Pharmaceuticals (XENE) has 7 years of Preferred Dividend Payments data on file, last reported at $17000.0 in Q4 2022.

• Preferred Dividend Payments for Q4 2022 came in at $17000.0, down 96.51% year-over-year; the trailing twelve-month figure through Dec 2022 was -$368000.0 (down 120.52% YoY), and the FY2022 annual result was $437000.0, down 75.65% from the prior year.
• Preferred Dividend Payments advanced to $17000.0 in Q4 2022 per XENE's latest filing, from -$684000.0 in the prior quarter.
• Over five years, Preferred Dividend Payments peaked at $1.6 million in Q3 2018 and troughed at -$684000.0 in Q2 2022.
• A 5-year average of $376421.1 and a median of $362000.0 in 2021 frame the typical range for Preferred Dividend Payments.
• The sharpest annual moves came in 2021 and 2022: Preferred Dividend Payments surged 10320.0% in 2021, then plunged 231.29% in 2022.
• A 5-year view of Preferred Dividend Payments shows it stood at $375000.0 in 2018, then rose by 12.53% to $422000.0 in 2019, then dropped by 17.06% to $350000.0 in 2020, then soared by 39.14% to $487000.0 in 2021, then plunged by 96.51% to $17000.0 in 2022.
• Business Quant data shows XENE's Preferred Dividend Payments at $17000.0 in Q4 2022, -$684000.0 in Q2 2022, and $299000.0 in Q1 2022.